During the past decade, Columbus Ophthalmology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Columbus Ophthalmology Associates" are "Acute Adenoviral Conjunctivitis" (1 trials) and "Blepharitis" (1 trials). Many other conditions were trialed in "Columbus Ophthalmology Associates" in a lesser frequency.

Most popular intervention types in "Columbus Ophthalmology Associates" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Azithromycin ophthalmic solution, 1%" (1 trials) and "FST-100 Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbus Ophthalmology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Columbus Ophthalmology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Columbus Ophthalmology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Columbus Ophthalmology Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".